Zai Lab's average Accounts Receivable for the
three
months ended in Mar. 2025 was $80.9 Mil. Zai Lab's Revenue for the
three
months ended in Mar. 2025 was $106.5 Mil.
Hence, Zai Lab's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 69.30.
The historical rank and industry rank for Zai Lab's Days Sales Outstanding or its related term are showing as below:
ZLAB'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.39 Med: 66.57 Max: 254.65
Current: 59.64
During the past 10 years, Zai Lab's highest Days Sales Outstanding was 254.65. The lowest was 33.39. And the median was 66.57.
ZLAB's Days Sales Outstanding is ranked better than 59.98% of 847
companies
in the Biotechnology industry
Industry Median: 70.2
vs ZLAB: 59.64
Zai Lab's Days Sales Outstanding
increased
from Mar. 2024 (62.63) to Mar. 2025 (69.30).
Zai Lab Days Sales Outstanding Historical Data
The historical data trend for Zai Lab's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zai Lab's Days Sales Outstanding
For the Biotechnology subindustry, Zai Lab's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zai Lab's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zai Lab's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Zai Lab's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zai Lab (NAS:ZLAB) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Zai Lab Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Zai Lab's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZLAB has been successfully added to your 